References
- Rudd RA, Seth P, David F, et al. Increases in drug and opioid-involved overdose deaths – United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65:1445–1452.
- Miller JM, Stogner JM, Miller BL, et al. Exploring synthetic heroin: accounts of acetyl fentanyl use from a sample of dually diagnosed drug offenders. Drug Alcohol Rev. 2017. [Epub ahead of print].
- Diaz Bode A, Singh M, Andrews J, et al. Fentanyl laced heroin and its contribution to a spike in heroin overdose in Miami-Dade County. Am J Emerg Med. 2017. [Epub ahead of print].
- Drug Enforcement Agency [Internet]. DEA intelligence brief. Counterfeit prescription pills containing fentanyls: a global threat. 2016. [cited 2017 Aug 1]. Available from: http://www.dea.gov/docs/Counterfeit%20Prescription%20Pills.pdf
- Higashikawa Y, Suzuki S. Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues. Forensic Toxicol. 2008;26:1–5.
- Janssen PA. Potent, new analgesics, tailor-made for different purposes. Acta Anaesthesiol Scand. 1982;26:262–268.
- Mather LE. Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet. 1983;8:422–446.
- Volpe DA, Mcmahon Tobin GA, Mellon RD, et al. Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs. Regul Toxicol Pharmacol. 2011;59:385–390.
- Wax PM, Becker CE, Curry SC. Unexpected “gas” casualties in Moscow: a medical toxicology perspective. Ann Emerg Med. 2003;41:700–705.
- Drug Enforcement Agency [Internet]. DEA warning to police and public: fentanyl exposure kills. 2016. [cited 2017 Aug 1]. Available from: http://www.dea.gov/divisions/hq/2016/hq061016.shtml
- National Institute for Occupational Safety and Health [Internet]. Fentanyl: preventing occupational exposure to emergency responders. 2016. [cited 2017 Aug 1]. Available from: http://www.cdc.gov/niosh/topics/fentanyl/risk.html
- McDaniels A. [Internet]. Deputy, two EMS providers treated for overdose symptoms responding to call. Baltimore (MD): The Baltimore Sun. 2017. [cited 2017 Aug 1]. Available from: http://www.baltimoresun.com/health/bs-md-harford-opioid-exposure-20170523-story.html
- Greenslade B. [Internet]. 3 Winnipeg police officers possibly exposed to fentanyl, self-administer naloxone. Global News. 2017. [cited 2017 Aug 1]. Available from: http://globalnews.ca/news/3471506/3-winnipeg-police-officerspossibly-exposed-to-fentanyl-self-administer-naloxone/
- Hung OR, Whynot SC, Varvel JR, et al. Pharmacokinetics of inhaled liposome-encapsulated fentanyl. Anesthesiology. 1995;83:277–284.
- Mather LE, Woodhouse A, Ward ME, et al. Pulmonary administration of aerosolised fentanyl: pharmacokinetic analysis of systemic delivery. Br J Clin Pharmacol. 1998;46:37–43.
- Riches JR, Read RW, Black RM, et al. Analysis of clothing and urine from Moscow theatre siege casualties reveals carfentanil and remifentanil use. J Anal Toxicol. 2012;36:647–656.
- Van Nimmen NFJ, Poels KLC, Veulemans HAF. Identification of exposure pathways for opioid narcotic analgesics in pharmaceutical production workers. Ann Occup Hyg. 2006;50:665–677.
- Gupta PK, Ganesan K, Gutch PK, et al. Vapor pressure and enthalpy of vaporization of fentanyl. J Chem Eng Data. 2008;53:841–845.
- Pastore MN, Kalia YN, Horstmann M, et al. Transdermal patches: history, development and pharmacology. Br J Pharmacol. 2015;172:2179–2209.
- Nelson L, Schwaner R. Transdermal fentanyl: pharmacology and toxicology. J Med Toxicol. 2009;5:230–241.
- Duthie DJ, Rowbotham DJ, Wyld R, et al. Plasma fentanyl concentrations during transdermal delivery of fentanyl to surgical patients. Br J Anaesth. 1988;60:614–618.
- Gourlay GK, Kowalski SR, Plummer JL, et al. The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects. Pain. 1989;37:193–202.
- Miguel R, Kreitzer JM, Reinhart D, et al. Postoperative pain control with a new transdermal fentanyl delivery system. A multicenter trial. Anesthesiology. 1995;83:470–477.
- Product Information: Duragesic (Fentanyl Transdermal System) for transdermal administration [Internet]. Janssen Pharmaceuticals. 2016. [cited 2017 Aug 1]. Available from: http://www.janssenmd.com/pdf/duragesic/duragesic_pi.pdf
- Sebel PS, Barrett CW, Kirk CJC, et al. Transdermal absorption of fentanyl and sufentanil in man. Eur J Clin Pharmacol. 1987;32:529–531.
- Rhodes J, Clay C, Phillips M. The surface area of the hand and the palm for estimating percentage of total body surface area: results of a meta-analysis. Br J Dermatol. 2013;169:76–84.
- Roy SD, Flynn GL. Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil. Pharm Res. 1990;7:842–847.
- George AV, Lu JJ, Pisano MV, et al. Carfentanil-an ultra potent opioid. Am J Emerg Med. 2010;28:530–532.
- Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367:146–155.
- Gussow L. Who said the opioid crisis couldn’t get any worse? Emerg Med News. 2016;38:1–29.
- Moresco A, Larsen RS, Sleeman JM, et al. Use of naloxone to reverse carfentanil citrate-induced hypoxemia and cardiopulmonary depression in Rocky Mountain wapiti (Cervus elaphus nelsoni). J Zoo Wildl Med. 2001;32:81–89.